Literature DB >> 6171904

Serum and sputum alpha 2 macroglobulin in patients with chronic obstructive airways disease.

D Burnett, R A Stockley.   

Abstract

Serum alpha 2 macroglobulin concentrations were measured in patients with chronic obstructive airways disease and an age-matched group of control subjects. The mean serum level of alpha 2 macroglobulin was significantly lower in bronchitic subjects with acute chest infections than the mean value of the controls. No significant differences were observed between serum alpha 2 macroglobulin values in controls, subjects with "emphysema", and bronchitic patients who did not have chest infections. Sputum alpha 2 macroglobulin concentrations were compared in sputum samples from bronchitic patients with and without acute chest infections. The protein was detected (greater than 0.2 mg/l) in 94% of sputum samples from infected subjects but only 60% of non-infected sputum samples. Concentrations of alpha 2 macroglobulin in infected samples were significantly higher than the non-infected samples. Sputum/serum concentration ratios of alpha 2 macroglobulin were also significantly higher in infected samples but this difference was eliminated by "correcting" the values with the albumin sputum/serum ratios of the same samples. The results suggest that alpha 2 macroglobulin concentrations are higher in bronchial secretions during chest infection because of increased transudation from the blood rather than the presence of significant local secretion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171904      PMCID: PMC1020433          DOI: 10.1136/thx.36.7.512

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  15 in total

1.  RADIOLOGY AND EMPHYSEMA.

Authors:  G SIMON
Journal:  Clin Radiol       Date:  1964-10       Impact factor: 2.350

2.  Studies in alpha 1-antitrypsin deficiency.

Authors:  S Eriksson
Journal:  Acta Med Scand Suppl       Date:  1965

3.  Serum derived protease inhibitors and leucocyte elastase in sputum and the effect of infection.

Authors:  R A Stockley; D Burnett
Journal:  Bull Eur Physiopathol Respir       Date:  1980

4.  Quantitation of human granulocyte protease inhibitors in non-purulent bronchial lavage fluids.

Authors:  H Tegner
Journal:  Acta Otolaryngol       Date:  1978 Mar-Apr       Impact factor: 1.494

5.  Proteases and protease inhibitors in chronic obstructive lung disease.

Authors:  S Erikson
Journal:  Acta Med Scand       Date:  1978

6.  The disappearance of enzyme-inhibitor complexes from the circulation of man.

Authors:  K Ohlsson; C B Laurell
Journal:  Clin Sci Mol Med       Date:  1976-07

7.  Granulocyte collagenase, elastase and plasma protease inhibitors in purulent sputum.

Authors:  K Ohlsson; H Tegner
Journal:  Eur J Clin Invest       Date:  1975-06-12       Impact factor: 4.686

8.  Characteristics of the macrophage uptake of proteinase-alpha-macroglobulin complexes.

Authors:  M T Debanne; R Bell; J Dolovich
Journal:  Biochim Biophys Acta       Date:  1976-04-23

9.  Protease inhibitors in chronic obstructive pulmonary disease.

Authors:  T B Barnett; D Gottovi; A M Johnson
Journal:  Am Rev Respir Dis       Date:  1975-05

10.  Degradation of tropoelastin and elastin substrates by human neutrophil elastase, free and bound to alpha2-macroglobulin in serum of the M and Z (Pi) phenotypes for alpha1-antitrypsin.

Authors:  M Galdston; V Levytska; I E Liener; D Y Twumasi
Journal:  Am Rev Respir Dis       Date:  1979-03
View more
  10 in total

1.  Sputum sol phase proteins and elastase activity in patients with clinically stable bronchiectasis.

Authors:  P Lloberes; E Montserrat; J M Montserrat; C Picado
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

Review 2.  Measurement of soluble proteins in lung secretions.

Authors:  R A Stockley
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

3.  Binding of native alpha 2-macroglobulin to human group G streptococci.

Authors:  H P Müller; L K Rantamäki
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

4.  Tissue inhibitor of metalloproteinases and collagenase inhibitory activity in lung secretions from patients with chronic obstructive bronchitis: effect of corticosteroid treatment.

Authors:  D Burnett; J J Reynolds; R V Ward; S C Afford; R A Stockley
Journal:  Thorax       Date:  1986-10       Impact factor: 9.139

5.  Vascular permeability of the middle ear mucosa in otitis media with effusion.

Authors:  Y Hamaguchi; S K Juhn
Journal:  Arch Otorhinolaryngol       Date:  1987

6.  Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

7.  Cardiac isoform of alpha 2 macroglobulin: a marker of cardiac involvement in pediatric HIV and AIDS.

Authors:  Ramachandran Meenakshisundaram; Shah Sweni; Ponniah Thirumalaikolundusubramanian
Journal:  Pediatr Cardiol       Date:  2010-02       Impact factor: 1.655

8.  Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment.

Authors:  R A Stockley; H M Morrison; J A Kramps; J H Dijkman; D Burnett
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

Review 9.  Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease.

Authors:  R Walter; D J Gottlieb; G T O'Connor
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

Review 10.  Plasma exudation and asthma.

Authors:  C G Persson
Journal:  Lung       Date:  1988       Impact factor: 2.584

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.